The global non-metastatic prostate cancer treatment market is a growing sector within the healthcare industry. Driven by an increasing prevalence of prostate cancer, coupled with advancements in diagnostic tools, this market is poised for significant expansion. Key players in the market are actively researching new therapies and treatment approache